Cours Anacor Pharmaceuticals Inc
Actions
US0324201013
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
2016 | Anacor Pharmaceuticals : Pfizer rachète Anacor Pharma pour 5,2 milliards de dollars | RE |
2016 | AbbVie : La chute des biotechs pourrait favoriser les fusions-acquisitions | RE |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 24/06/16 |
Chief Tech/Sci/R&D Officer | 77 | 01/02/04 | |
Director/Board Member | - | 24/06/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 24/06/16 |
Bryan Supran
BRD | Director/Board Member | - | 24/06/16 |
Director/Board Member | - | 24/06/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,38% | 42,86 Md | |
+12,43% | 42,74 Md | |
+44,76% | 41,36 Md | |
-8,83% | 27,68 Md | |
+7,32% | 25,15 Md | |
-23,14% | 18,63 Md | |
+29,85% | 12,37 Md | |
-2,87% | 11,92 Md | |
+7,33% | 11,21 Md |